TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,027,000 | +41.8% | 166,201 | +50.8% | 0.23% | +154.3% |
| Q1 2022 | $2,840,000 | -16.8% | 110,225 | +0.3% | 0.09% | -25.8% |
| Q4 2021 | $3,412,000 | +161.7% | 109,925 | +104.4% | 0.12% | +210.0% |
| Q3 2021 | $1,304,000 | -15.2% | 53,790 | -49.0% | 0.04% | -16.7% |
| Q2 2021 | $1,538,000 | -51.3% | 105,382 | -16.7% | 0.05% | -46.7% |
| Q1 2021 | $3,160,000 | – | 126,533 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |